From luxury brands entering new markets to boutique concepts popping up in wondrous natural settings, 2025 promises a glut of ...

Austria. All pre-clinical programs will also be paused. Story Feb. 5 - Viracta Therapeutics: The cancer biotech has closed its doors, laying off all employees and winding down operations.